RG
Redmile Group Portfolio holdings
AUM
$940M
This Quarter Return
+55.06%
1 Year Return
+75.78%
3 Year Return
+543.67%
5 Year Return
+585.96%
10 Year Return
+6,653.82%
AUM
$2.8B
AUM Growth
+$2.8B
(+33%)
Cap. Flow
+$38.5M
Cap. Flow
% of AUM
1.38%
Top 10 Holdings %
Top 10 Hldgs %
54.31%
Holding
75
New
7
Increased
22
Reduced
26
Closed
5
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$67.7M |
| 2 |
Immunome
IMNM
|
$41.5M |
| 3 |
Biohaven
BHVN
|
$39.6M |
| 4 |
ALX Oncology
ALXO
|
$35.4M |
| 5 |
IDEAYA Biosciences
IDYA
|
$33.3M |
Top Sells
| 1 |
SNCE
Science 37 Holdings, Inc. Common Stock
SNCE
|
$100M |
| 2 |
Krystal Biotech
KRYS
|
$33.5M |
| 3 |
IMGN
Immunogen Inc
IMGN
|
$32M |
| 4 |
Amicus Therapeutics
FOLD
|
$30M |
| 5 |
Elevance Health
ELV
|
$29.4M |
Sector Composition
| 1 | Healthcare | 94.12% |
| 2 | Industrials | 3.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
IDEAYA Biosciences
IDYA
$2.25B
| $33.3M | 1.19% |
+935,863
| New | +$33.3M |
|
27
Replimune Group
REPL
$459M
| $32.6M | 1.17% |
3,865,258
-298,664
| -7% | -$2.52M |
|
28
Cabaletta Bio
CABA
$141M
| $31.2M | 1.12% |
1,374,189
-400,063
| -23% | -$9.08M |
|
29
Abbott
ABT
$228B
| $29.2M | 1.05% |
+265,500
| New | +$29.2M |
|
30
Evolent Health
EVH
$1.09B
| $27.6M | 0.99% |
835,537
+370,255
| +80% | +$12.2M |
|
31
Akero Therapeutics
AKRO
$3.62B
| $25.9M | 0.93% |
1,109,476
-660,208
| -37% | -$15.4M |
|
32
ADC Therapeutics
ADCT
$359M
| $25.4M | 0.91% |
15,328,317
+1,150,272
| +8% | +$1.91M |
|
33
Annexon
ANNX
$230M
| $25M | 0.89% |
5,503,190
+2,000,000
| +57% | +$9.08M |
|
|
IGMS
34
DELISTED
IGM Biosciences
IGMS
| $24.7M | 0.88% |
2,971,542
| – | – |
|
|
VERV
35
DELISTED
Verve Therapeutics
VERV
| $24M | 0.86% |
1,718,669
+908,892
| +112% | +$12.7M |
|
36
Penumbra
PEN
$10.5B
| $24M | 0.86% |
95,242
-59,834
| -39% | -$15.1M |
|
37
89bio
ETNB
$1.36B
| $22M | 0.79% |
1,969,402
+1,207,447
| +158% | +$13.5M |
|
38
Charles River Laboratories
CRL
$7.91B
| $20.5M | 0.73% |
86,782
+20,400
| +31% | +$4.82M |
|
39
Entrada Therapeutics
TRDA
$202M
| $19.4M | 0.69% |
1,283,735
-265
| -0% | -$4K |
|
40
Neurogene
NGNE
$275M
| $18.4M | 0.66% |
946,897
+364,454
| +63% | +$7.06M |
|
41
Intuitive Surgical
ISRG
$156B
| $18.3M | 0.65% |
+54,258
| New | +$18.3M |
|
42
HCA Healthcare
HCA
$94.9B
| $17.9M | 0.64% |
66,100
+41,433
| +168% | +$11.2M |
|
43
Cogent Biosciences
COGT
$1.81B
| $17.1M | 0.61% |
2,914,022
+860,689
| +42% | +$5.06M |
|
44
Stryker
SYK
$147B
| $15.9M | 0.57% |
53,141
-41,597
| -44% | -$12.5M |
|
45
Repare Therapeutics
RPTX
$73.5M
| $15.7M | 0.56% |
2,148,748
-255,947
| -11% | -$1.87M |
|
46
Stoke Therapeutics
STOK
$1.09B
| $13.8M | 0.49% |
2,625,506
-1,247,190
| -32% | -$6.56M |
|
47
Align Technology
ALGN
$9.57B
| $13.7M | 0.49% |
+50,082
| New | +$13.7M |
|
|
GRTS
48
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $12M | 0.43% |
5,872,605
-2,636,521
| -31% | -$5.38M |
|
49
Prime Medicine
PRME
$590M
| $11.7M | 0.42% |
1,324,350
| – | – |
|
|
50
Elevance Health
ELV
$72.4B
| $10.9M | 0.39% |
23,079
-62,299
| -73% | -$29.4M |
|